{
  "trial_id": "NCT02067520",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Patient undergoing a primary or repeat elective, scheduled C/S",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The study will be explained to her, the possible risks, benefits, and alternatives will be discussed, she will be given the opportunity to ask questions and if she agrees, the consent will be signed.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The dose of IT hydromorphone will be determined and made up by our statistician physician.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Data will be collected over the next 16 hours according to the above research design.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Risks of any narcotic medication include analgesia, drowsiness, mental clouding, changes in mood, euphoria or dysphoria, respiratory depression, cough suppression, decreased gastrointestinal motility, nausea, vomiting, increased cerebrospinal fluid pressure, increased biliary pressure, pinpoint constriction of the pupils, increased parasympathetic activity and transient hyperglycemia.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Standard nursing orders will include monitoring respiratory rate every 1 hour for 6 hours, then every 2 hours for 6 hours, for signs of respiratory depression, use of pulse oximetry, and administration of naloxone if needed.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Potential benefit of the study is pain relief in the postoperative period following C/S (Our usual medication is currently unavailable or in critically limited supply).",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The side effect profiles for our standard drug, IT morphine and the study drug IT hydromorphone are similar.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "This study poses minimal risk. This is a dose finding study. The dosages the investigators will use are well below documented safe doses of this drug for the IT route.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Females undergoing a primary or repeat elective, scheduled C/S who are not yet in labor.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patient refusal",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Age less than 18 years",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Onset of labor",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Current opioid abuse",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Use of methadone maintenance for previous opioid abuse",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Allergy to hydromorphone",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Contraindication to spinal anesthesia",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient is a 19-year-old Hispanic female in her 32nd week of gestation, presenting with mild headache and leg swelling. She has no specific past medical issues and only uses prenatal vitamins.",
  "_meta": {
    "topic_id": "42",
    "trial_id": "NCT02067520",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}